Dr. John Mekras, M.D.,P.H.D.
What this data tells you about Dr. Mekras
Dr. John Mekras is an urology physician in South Miami, FL, with 19 years in practice. Based on federal Medicare data, Dr. Mekras performed 5,807 Medicare services across 3,856 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mekras received a total of $2,913 from 20 pharmaceutical and/or device companies across 100 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mekras is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) | 1,441 | $7 | $8 |
| Office visit, established patient (20-29 min) | 876 | $65 | $98 |
| Office visit, established patient (10-19 min) | 799 | $42 | $62 |
| Hospital follow-up visit, low complexity | 493 | $43 | $55 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 233 | $133 | $252 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 197 | $72 | $94 |
| New patient office visit (30-44 min) | 192 | $82 | $124 |
| Complete ultrasound scan behind abdominal cavity | 183 | $86 | $116 |
| Simple insertion of temporary bladder tube | 164 | $45 | $67 |
| Bladder ultrasound after voiding | 162 | $8 | $12 |
| Office visit, established patient (30-39 min) | 155 | $101 | $137 |
| Hospital follow-up visit, moderate complexity | 135 | $65 | $86 |
| Diagnostic exam of bladder and urethra using an endoscope | 119 | $187 | $263 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 91 | $28 | $36 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 87 | $17 | $25 |
| Limited ultrasound scan of pelvis | 76 | $26 | $39 |
| Injection, garamycin, gentamicin, up to 80 mg | 74 | $2 | $5 |
| New patient office or other outpatient visit, 15-29 minutes | 73 | $50 | $83 |
| Initial hospital admission, moderate complexity | 37 | $112 | $154 |
| Insertion of stent in ureter using an endoscope | 35 | $117 | $224 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 26 | $363 | $478 |
| Ultrasound scan of pelvic region through rectum | 25 | $22 | $72 |
| Needle biopsy of prostate gland using image guidance | 23 | $309 | $437 |
| Insertion of temporary bladder tube | 22 | $35 | $50 |
| Complete laser vaporization of prostate including control of bleeding using an endoscope | 21 | $608 | $788 |
| Simple bladder irrigation and/or instillation | 18 | $57 | $86 |
| Injection procedure to cause erection | 17 | $65 | $105 |
| New patient office visit (45-59 min) | 17 | $134 | $207 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 16 | $128 | $241 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mekras is a clinical cardiology specialist, with above-average Medicare volume (top 21% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mekras experienced with blood draw (venipuncture)?
Does Dr. Mekras receive payments from pharmaceutical companies?
How do Dr. Mekras's costs compare to other urology physicians in South Miami?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology